WANDA HAYNES: Open Payments
NPI 1235329764 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,435 in 45 payments from 20 companies in 2025. Trend: 2023 $233 · 2024 $1,406 · 2025 $1,435
Food & beverage: $1,435
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 8 | $176 |
| Tandem Diabetes Care, Inc. | 4 | $163 |
| Novo Nordisk Inc | 3 | $159 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Lilly USA, LLC | 6 | $123 |
| Amgen Inc. | 3 | $119 |
| Otsuka America Pharmaceutical, Inc. | 1 | $107 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $77 |
| Xeris Pharmaceuticals, Inc. | 3 | $58 |
| Dexcom, Inc. | 2 | $57 |
Products named: FREESTYLE LIBRE 3, t:slim X2 Insulin Pump with Control-IQ, Ozempic, AIRSUPRA, MOUNJARO, REXULTI, EVENITY, JARDIANCE.
Industry payments across MO — which companies pay providers there.
